[登录] [免费注册]
试剂仪器网
位置:首页 > 资料中心 > 化工字典 > 952652-79-8
关键词:       仅模糊查询
CAS: 952652-79-8
分子式: C23H27N5O3
分子量: 421.49
熔点: >149° C(dec.)
中文名称: 
(S)-n-丁酰基-n-{[2'-(1h-四唑-5-基)联苯-4-基]甲基}缬氨酸
缬沙坦杂质b, 2-四唑联苯-4-氨基(丁酰基)-n-1'-异丙基乙酸
英文名称: 
(S)-n-butyryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine
valsartan n-propyl
推荐供应商
货号品牌产品名称规格包装、参考价格
S960390MACKLIN2-四唑联苯-4-氨基(丁酰基)-N-1'-异丙基乙酸≥95%2319元/10mg;   咨询
储存:2-8°C
968270J&K(S)-N-Butyryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine95%1593元/10MG;   咨询

基本信息

分子式C23H27N5O3
分子量421.49
熔点148-150
存储条件Store at 2-8℃

安全信息

防范说明P262
PHR1876SupelcoValsartan Related Compound BPharmaceutical Secondary Standard; Certified Reference Material6002.55元/30 MG;   咨询

产品说明

一般描述

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

分析说明

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他说明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

附注

To see an example of a Certificate of Analysis for this material enter LRAB1042 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

基本信息

经验(实验)分子式C23H27N5O3
分子量421.49
MDL编号MFCD19689078
NACRESNA.24

产品性质

质量水平300
等级certified reference material
pharmaceutical secondary standard
CofAcurrent certificate can be downloaded
包装pkg of 30 mg
application(s)pharmaceutical
格式neat
药典可追溯性traceable to USP 1708784
储存温度2-8℃
SMILES stringCCCC(=O)N(Cc1ccc(cc1)-c2ccccc2-c3nnn[nH]3)[C@@H](C(C)C)C(O)=O
InChI1S/C23H27N5O3/c1-4-7-20(29)28(21(15(2)3)23(30)31)14-16-10-12-17(13-11-16)18-8-5-6-9-19(18)22-24-26-27-25-22/h5-6,8-13,15,21H,4,7,14H2,1-3H3,(H,30,31)(H,24,25,26,27)/t21-/m0/s1
InChI keyOKAQHVJSXLGXET-NRFANRHFSA-N

安全信息

象形图GHS07GHS08
警示用语:Warning
危险声明H336 - H361d
预防措施声明P202 - P261 - P271 - P280 - P304 + P340 + P312 - P308 + P313
危险分类Repr. 2 - STOT SE 3
靶器官Central nervous system
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
1708784USPValsartan Related Compound BUnited States Pharmacopeia (USP) Reference Standard14120.9元/10 MG;   咨询

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Valsartan Related Compound B was used as working standard during validation of HPLC method for quantifying valsartan and hydrochlorthiazide combination from tablet formulation.

分析说明

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他说明

USP issued SDS can be found here.
Sales restrictions may apply.

基本信息

经验(实验)分子式C23H27N5O3
分子量421.49
MDL编号MFCD19689078
PubChem化学物质编号329751481
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameUSP
application(s)pharmaceutical (small molecule)
格式neat
SMILES stringCCCC(=O)N(Cc1ccc(cc1)-c2ccccc2-c3nnn[nH]3)[C@@H](C(C)C)C(O)=O
InChI1S/C23H27N5O3/c1-4-7-20(29)28(21(15(2)3)23(30)31)14-16-10-12-17(13-11-16)18-8-5-6-9-19(18)22-24-26-27-25-22/h5-6,8-13,15,21H,4,7,14H2,1-3H3,(H,30,31)(H,24,25,26,27)/t21-/m0/s1
InChI keyOKAQHVJSXLGXET-NRFANRHFSA-N

安全信息

象形图GHS07GHS08
警示用语:Warning
危险声明H336 - H361d
预防措施声明P202 - P261 - P271 - P280 - P304 + P340 + P312 - P308 + P313
危险分类Repr. 2 - STOT SE 3
靶器官Central nervous system
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
CAS号首数字顺序排列: 1 2 3 4 5 6 7 8 9